香港股市 已收市
  • 恒指

    17,222.83
    +56.96 (+0.33%)
     
  • 國指

    5,914.08
    +1.83 (+0.03%)
     
  • 上證綜指

    3,024.39
    -16.81 (-0.55%)
     
  • 滬深300

    3,804.89
    -22.26 (-0.58%)
     
  • 美元

    7.8497
    +0.0002 (+0.00%)
     
  • 人民幣

    0.9058
    -0.0014 (-0.15%)
     
  • 道指

    29,139.30
    -86.31 (-0.30%)
     
  • 標普 500

    3,642.68
    +2.21 (+0.06%)
     
  • 納指

    10,785.92
    +48.42 (+0.45%)
     
  • 日圓

    0.0540
    -0.0001 (-0.15%)
     
  • 歐元

    7.6828
    -0.0232 (-0.30%)
     
  • 英鎊

    8.7380
    +0.0100 (+0.11%)
     
  • 紐約期油

    81.06
    -0.17 (-0.21%)
     
  • 金價

    1,681.60
    +13.00 (+0.78%)
     
  • Bitcoin

    19,871.35
    +576.05 (+2.99%)
     
  • CMC Crypto 200

    452.01
    +8.58 (+1.93%)
     

Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal

·1 分鐘文章
  • Ginkgo Bioworks Holdings Inc (NYSE: DNAagreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction.

  • Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo.

  • Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, including machine learning and data science tools for exploring genetic design space.

  • The agreement represents Ginkgo's largest acquisition to date and is expected to significantly enhance Ginkgo's platform by integrating robust automation and software capabilities.

  • Ginkgo customers will also benefit from expanding Ginkgo's library of biological assets ("Codebase") following the transaction.

  • The transaction is expected to be completed by the first quarter of 2023.

  • Price Action: DNA shares are down 4.62% at $2.79, and ZY stock is up 18.8% at $2.38 during the market session on the last check Monday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.